BF Suma Pharmaceuticals, Inc.
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Undeclared allergens due to sub-ingredients, soy lecithin and coconut oil
Longreen Corporation 4 in1 Reishi Coffee, 18.2 grams/sachet, 10 sachets/box
Batch No. A34319, Best By Date: 12 2025; Batch No. A34419, Best By Date: 12 2025; Batch No. E34519, Best By Date: 04 2026; Batch No. E34619, Best By Date: 04 2026; Batch No. F34119, Best By Date: 05 2026; Batch No. F34219, Best By Date: 05 2026; Batch No. H34519, Best By Date: 07 2026; Batch No. H34619, Best By Date: 07 2026; Batch No. A43119, Best By Date: 12 2026; Batch No. A43219, Best By Date: 12 2026; Batch No. B41119, Best By Date: 01 2027; Batch No. B41219, Best By Date: 01 2027
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →